APVO logo

Aptevo Therapeutics (APVO) Long Term Debt

Annual Long Term Debt

$5.40 M
-$2.14 M-28.37%

December 31, 2023


Summary


Performance

APVO Long Term Debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherAPVObalance sheetmetrics:

Quarterly Long Term Debt

$4.83 M
-$195.00 K-3.88%

September 30, 2024


Summary


Performance

APVO Quarterly Long Term Debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherAPVObalance sheetmetrics:

Long Term Debt Formula

Long-Term Debt = Bonds Payable + Long-Term Loans + Mortgage Payable + Other Long-Term Borrowings − Current Portion of Long-Term Debt

APVO Long Term Debt Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-28.4%-10.5%
3 y3 years-75.9%-10.5%
5 y5 years-72.0%+45.2%

APVO Long Term Debt Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-28.4%+6.9%-44.8%+24.8%
5 y5-year-75.9%+62.2%-82.6%+69.1%
alltimeall time-75.9%+62.2%-82.6%+69.1%

Aptevo Therapeutics Long Term Debt History

DateAnnualQuarterly
Sep 2024
-
$4.83 M(-3.9%)
Jun 2024
-
$5.03 M(-3.6%)
Mar 2024
-
$5.21 M(-3.4%)
Dec 2023
$5.40 M(-28.4%)
$5.40 M(-3.2%)
Sep 2023
-
$5.58 M(-3.0%)
Jun 2023
-
$5.75 M(-2.8%)
Mar 2023
-
$5.92 M(-21.5%)
Dec 2022
$7.54 M(+49.3%)
$7.54 M(-7.5%)
Sep 2022
-
$8.15 M(-6.9%)
Jun 2022
-
$8.75 M(+126.1%)
Mar 2022
-
$3.87 M(-23.4%)
Dec 2021
$5.05 M(-77.5%)
$5.05 M(-10.2%)
Sep 2021
-
$5.62 M(-9.2%)
Jun 2021
-
$6.19 M(-8.0%)
Mar 2021
-
$6.73 M(-70.0%)
Dec 2020
$22.41 M
$22.41 M(-19.4%)
DateAnnualQuarterly
Sep 2020
-
$27.80 M(+873.1%)
Jun 2020
-
$2.86 M(-7.8%)
Mar 2020
-
$3.10 M(-6.9%)
Dec 2019
$3.33 M(-82.7%)
$3.33 M(-6.2%)
Sep 2019
-
$3.55 M(-84.8%)
Jun 2019
-
$23.32 M(-0.4%)
Mar 2019
-
$23.41 M(+21.4%)
Dec 2018
$19.28 M(+22.6%)
$19.28 M(+0.7%)
Sep 2018
-
$19.14 M(+24.3%)
Jun 2018
-
$15.40 M(+10.2%)
Mar 2018
-
$13.97 M(-11.1%)
Dec 2017
$15.73 M(-14.4%)
$15.73 M(-10.0%)
Sep 2017
-
$17.48 M(-6.7%)
Jun 2017
-
$18.75 M(+1.7%)
Mar 2017
-
$18.43 M(+0.3%)
Dec 2016
$18.38 M
$18.38 M(+1.5%)
Sep 2016
-
$18.11 M

FAQ

  • What is Aptevo Therapeutics annual long term debt?
  • What is the all time high annual long term debt for Aptevo Therapeutics?
  • What is Aptevo Therapeutics annual long term debt year-on-year change?
  • What is Aptevo Therapeutics quarterly long term debt?
  • What is the all time high quarterly long term debt for Aptevo Therapeutics?
  • What is Aptevo Therapeutics quarterly long term debt year-on-year change?

What is Aptevo Therapeutics annual long term debt?

The current annual long term debt of APVO is $5.40 M

What is the all time high annual long term debt for Aptevo Therapeutics?

Aptevo Therapeutics all-time high annual long term debt is $22.41 M

What is Aptevo Therapeutics annual long term debt year-on-year change?

Over the past year, APVO annual long term debt has changed by -$2.14 M (-28.37%)

What is Aptevo Therapeutics quarterly long term debt?

The current quarterly long term debt of APVO is $4.83 M

What is the all time high quarterly long term debt for Aptevo Therapeutics?

Aptevo Therapeutics all-time high quarterly long term debt is $27.80 M

What is Aptevo Therapeutics quarterly long term debt year-on-year change?

Over the past year, APVO quarterly long term debt has changed by -$567.00 K (-10.51%)